Doma Perpetual Capital Management’s Pacira BioSciences PCRX Stock Holding History

Doma Perpetual Capital Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$70.5M	Hold	2,777,794	–	–	16.36%	1
2026 Q1	$62.8M	Hold	2,777,794	–	–	16.86%	1
2025 Q4	$71.9M	Buy	2,777,794 +76,470	+3%	+$1.82M	20.21%	1
2025 Q3	$69.6M	Buy	2,701,324 +897,255	+50%	+$22M	23.38%	1
2025 Q2	$43.1M	Hold	1,804,069	–	–	16.33%	2
2025 Q1	$44.8M	Buy	1,804,069 +56,220	+3%	+$1.35M	17.62%	1
2024 Q4	$32.9M	Hold	1,747,849	–	–	16.39%	2
2024 Q3	$26.3M	Buy	1,747,849 +747,088	+75%	+$12.8M	13.29%	5
2024 Q2	$28.6M	Buy	1,000,761 +418,321	+72%	+$11.9M	13.28%	3
2024 Q1	$17M	Buy	582,440 +396,119	+213%	+$12.2M	11.32%	3
2023 Q4	$6.29M	Buy	+186,321	New	+$5.45M	6.2%	6

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Doma Perpetual Capital Management's PCRX Position: Q2 2026 in Review

Doma Perpetual Capital Management held its Pacira BioSciences (PCRX) position steady in Q2 2026 at 2,777,794 shares worth $70.5M. The position accounts for 16.36% of the portfolio, ranked #1.

Doma Perpetual Capital Management first reported a position in PCRX in Q4 2023 and has held it in 11 quarters since. The position peaked at $71.9M in Q4 2025. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Doma Perpetual Capital Management held 2,777,794 shares of Pacira BioSciences worth $70.5M as of Q2 2026.
Doma Perpetual Capital Management left its Pacira BioSciences share count unchanged in Q2 2026.
Pacira BioSciences made up 16.36% of Doma Perpetual Capital Management's portfolio in Q2 2026, its #1 holding.
Doma Perpetual Capital Management first reported a position in Pacira BioSciences in Q4 2023 and has held it in 11 quarters since.
Doma Perpetual Capital Management's Pacira BioSciences position peaked at $71.9M in Q4 2025.
253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Doma Perpetual Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.